-
Abstract Number: 1634
Comparison of Different Pulmonary Hypertension Screening Algorithms in Patients with Systemic Sclerosis
-
Abstract Number: 1635
Correlation Between Raynaud’s Condition Score, Nailfold Videocapillaroscopy and Laser Speckle Contrast Analysis in Secondary Raynaud’s Phenomenon Due to Systemic Sclerosis
-
Abstract Number: 1636
Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial
-
Abstract Number: 1637
The Clinical Features of Anti-RNA Polymerase III Antibodypositive Systemic Sclerosis with and Without Malignancy
-
Abstract Number: 1638
Sexual Health in 60 Female Patients with Systemic Sclerosis
-
Abstract Number: 1639
Endoscopic Findings in a Scleroderma Cohort with and Without Interstitial Lung Disease
-
Abstract Number: 1640
Cutaneous and Musculoskeletal Clinical Characterization of a Cohort of Patients with Chronic Graft-versus-host Disease
-
Abstract Number: 1641
Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis
-
Abstract Number: 1642
Automated Nailfold Capillary Counting System (AUTOCAPI) in Systemic Sclerosis Patients with Different Capillaroscopic Patterns
-
Abstract Number: 1643
Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial by Corticosteroid Use
-
Abstract Number: 1644
Effects of Nintedanib in Patients with Diffuse and Limited Cutaneous Systemic Sclerosis and Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial
-
Abstract Number: 1645
Comparison of Automated Capture and Analysis System of Sublingual Microvessels and Nailfold Videocapillarscopy for Microvascular Assessment in Systemic Sclerosis
-
Abstract Number: 1646
Incidence Rate and Prevalence of Valvular Heart Disease in Systemic Sclerosis: A Retrospective Cohort Study from a Single Institution
-
Abstract Number: 1647
The Collaborative National Quality and Efficacy Registry for Scleroderma: Data Completion Outcomes from a Multicenter United States Cohort Using Guideline-Based Registry Practices
-
Abstract Number: 1648
Systemic Sclerosis Auto-antibody Profiles Predict Interstitial Lung Disease Onset but Not Progression
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 198
- Next Page »